Valuation: Photocure ASA

Market Cap 1.5B 156M 137M 127M 117M 220M 15.06B 223M 1.51B 592M 7.37B 586M 573M 25.45B P/E 2026 *
16.6x
P/E 2027 * 34.9x
Enterprise Value 1.3B 135M 118M 110M 101M 190M 13.02B 193M 1.31B 512M 6.37B 507M 496M 22.01B EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.92x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+1.24%
1 week-1.04%
Current month-3.88%
1 month-5.79%
3 months-18.10%
6 months-21.27%
Current year-20.17%
1 week 54.8
Extreme 54.8
58.6
1 month 54.8
Extreme 54.8
61.8
Current year 54.8
Extreme 54.8
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 31/10/2018
Chief Tech/Sci/R&D Officer - 31/07/2021
Human Resources Officer - 31/01/2021
Director TitleAgeSince
Director/Board Member - 31/12/2021
Chairman - 26/09/2023
Director/Board Member - 22/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%-1.04%-7.62%+19.12% 156M
-1.05%+0.55%+49.79%+151.71% 1,037B
+2.00%+3.49%+52.22%+50.20% 615B
-1.09%+3.76%+35.37%+76.22% 448B
+1.96%+2.47%+30.04%+24.24% 326B
-1.23%+0.81%+33.44%+36.85% 293B
-1.61%-0.84%+17.31%+16.16% 264B
-1.82%-6.61%-29.18%-42.98% 216B
-0.05%+2.16%+19.75%+55.89% 198B
+0.05%-1.03%+18.31%+61.63% 162B
Average -0.10%+0.72%+21.94%+44.90% 355.76B
Weighted average by Cap. -0.50%+1.47%+34.94%+72.25%

Financials

2026 *2027 *
Net sales 660M 68.72M 60.21M 55.9M 51.36M 96.79M 6.63B 98.21M 666M 261M 3.24B 258M 252M 11.21B 665M 69.24M 60.67M 56.32M 51.75M 97.52M 6.68B 98.95M 671M 263M 3.27B 260M 254M 11.29B
Net income 91.33M 9.51M 8.34M 7.74M 7.11M 13.4M 918M 13.6M 92.19M 36.08M 449M 35.72M 34.95M 1.55B 43.33M 4.51M 3.96M 3.67M 3.37M 6.36M 436M 6.45M 43.74M 17.12M 213M 16.95M 16.58M 736M
Net Debt -203M -21.11M -18.5M -17.17M -15.78M -29.74M -2.04B -30.17M -205M -80.07M -997M -79.25M -77.54M -3.44B -221M -23.06M -20.2M -18.75M -17.23M -32.47M -2.22B -32.95M -223M -87.44M -1.09B -86.55M -84.68M -3.76B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
23/07/26 NOK 57.00 +1.24% 13,677
22/07/26 NOK 56.30 0.00% 48,088
21/07/26 NOK 56.30 -2.26% 84,627
20/07/26 NOK 57.60 -0.17% 12,401
17/07/26 NOK 57.70 +0.17% 20,065
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.30NOK
Average target price
84.00NOK
Spread / Average Target
+49.20%

Quarterly revenue - Rate of surprise